Intravenous Hydroxypropyl β‐Cyclodextrin Formulation of Letermovir: A Phase I, Randomized, Single‐Ascending, and Multiple‐Dose Trial

por Erb‐Zohar, K, Kropeit, D, Scheuenpflug, J, Stobernack, H‐P, Hulskotte, EGJ, van Schanke, A, Zimmermann, H, Rübsamen‐Schaeff, H
Publicado 2017